Screen of DM by OGTT in Subjects Receiving CAG or MDCT for CAD
Study Details
Study Description
Brief Summary
To determine the glucose regulation status of patients who were suspected to have CAD in central Taiwan.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
It had been reported that high prevalence of IGT (impaired glucose tolerance) and unknown DM (diabetes mellitus) in patients with CAD (coronary artery disease). This study aimed to determine the glucose regulation status of patients who were suspected to have CAD in central Taiwan. In general, patient who were admitted for CAG (coronary angiography) or MDCT without known DM were eligible. After informed consent, OGTT (oral glucose tolerance test) was performed to determine the glucose regulation status. Study participants will be requested to complete questionnaires to assess their risk of diabetes and quality of sleep. Patients who were diagnosed as new DM would be asked to follow up in clinical service with diet control.
Study Design
Outcome Measures
Primary Outcome Measures
- Diabetes [3 months]
Based on OGTT and HbA1c
Secondary Outcome Measures
- Brain-derived neurotrophic factor [3 months]
An biomarker to link brain and atheroclerosis
- Coroanry artery disease [3 months]
Based on coronary angiography and medical record
- Mortality [5 years]
All-cause and cardiovascular
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient received CAG or MDCT for suspect CAD
-
Without DM history
Exclusion Criteria:
-
Known DM
-
Unstable disease condition
-
Pregnancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Taichung Veterans General Hospital | Taichung | Taiwan | 40705 |
Sponsors and Collaborators
- Taichung Veterans General Hospital
Investigators
- Principal Investigator: Wayne H-H Sheu, MD, PHD, Taichung Veterans General Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- C08215